These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 23395839)

  • 1. Identification of a molecular profile associated with immune status in first-onset schizophrenia patients.
    Herberth M; Rahmoune H; Schwarz E; Koethe D; Harris LW; Kranaster L; Witt SH; Spain M; Barnes A; Schmolz M; Leweke MF; Guest PC; Bahn S
    Clin Schizophr Relat Psychoses; 2014 Jan; 7(4):207-15. PubMed ID: 23395839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a blood-based biological signature in subjects with psychiatric disorders prior to clinical manifestation.
    Schwarz E; Guest PC; Rahmoune H; Martins-de-Souza D; Niebuhr DW; Weber NS; Cowan DN; Yolken RH; Spain M; Barnes A; Bahn S
    World J Biol Psychiatry; 2012 Dec; 13(8):627-32. PubMed ID: 21936765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Label-free quantitative proteomic analysis reveals dysfunction of complement pathway in peripheral blood of schizophrenia patients: evidence for the immune hypothesis of schizophrenia.
    Li Y; Zhou K; Zhang Z; Sun L; Yang J; Zhang M; Ji B; Tang K; Wei Z; He G; Gao L; Yang L; Wang P; Yang P; Feng G; He L; Wan C
    Mol Biosyst; 2012 Oct; 8(10):2664-71. PubMed ID: 22797129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Peripheral blood T-lymphocyte and T-lymphocyte subset ratios before and after treatment in schizophrenia patients not taking antipsychotic medication].
    Baskak SC; Ozsan H; Baskak B; Devrimci Ozgüven H; Kinikli G
    Turk Psikiyatri Derg; 2008; 19(1):5-12. PubMed ID: 18330738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired glycolytic response in peripheral blood mononuclear cells of first-onset antipsychotic-naive schizophrenia patients.
    Herberth M; Koethe D; Cheng TM; Krzyszton ND; Schoeffmann S; Guest PC; Rahmoune H; Harris LW; Kranaster L; Leweke FM; Bahn S
    Mol Psychiatry; 2011 Aug; 16(8):848-59. PubMed ID: 20585325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic, hormonal and stress-related molecular changes in post-mortem pituitary glands from schizophrenia subjects.
    Krishnamurthy D; Harris LW; Levin Y; Koutroukides TA; Rahmoune H; Pietsch S; Vanattou-Saifoudine N; Leweke FM; Guest PC; Bahn S
    World J Biol Psychiatry; 2013 Sep; 14(7):478-89. PubMed ID: 22248022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble interleukin-2 receptor levels correlated with positive symptoms during quetiapine treatment in schizophrenia-spectrum disorders.
    Igue R; Potvin S; Bah R; Stip E; Bouchard RH; Lipp O; Gendron A; Kouassi E
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1695-8. PubMed ID: 21627977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression profiling of fibroblasts identifies cell cycle abnormalities in schizophrenia.
    Wang L; Lockstone HE; Guest PC; Levin Y; Palotás A; Pietsch S; Schwarz E; Rahmoune H; Harris LW; Ma D; Bahn S
    J Proteome Res; 2010 Jan; 9(1):521-7. PubMed ID: 19916557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood biomarker discovery in drug-free schizophrenia: the contributionof proteomics and multiplex immunoassays.
    Sabherwal S; English JA; Föcking M; Cagney G; Cotter DR
    Expert Rev Proteomics; 2016 Dec; 13(12):1141-1155. PubMed ID: 27771981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered levels of circulating insulin and other neuroendocrine hormones associated with the onset of schizophrenia.
    Guest PC; Schwarz E; Krishnamurthy D; Harris LW; Leweke FM; Rothermundt M; van Beveren NJ; Spain M; Barnes A; Steiner J; Rahmoune H; Bahn S
    Psychoneuroendocrinology; 2011 Aug; 36(7):1092-6. PubMed ID: 21251762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Converging evidence of blood-based biomarkers for schizophrenia: an update.
    Chan MK; Guest PC; Levin Y; Umrania Y; Schwarz E; Bahn S; Rahmoune H
    Int Rev Neurobiol; 2011; 101():95-144. PubMed ID: 22050850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects on T-cell function following exposure to serum from schizophrenia smokers.
    Herberth M; Krzyszton DN; Koethe D; Craddock MR; Bulger E; Schwarz E; Guest P; Leweke FM; Bahn S
    Mol Psychiatry; 2010 Apr; 15(4):364-71. PubMed ID: 19002140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of proteomic biomarkers for improved diagnosis and stratification of schizophrenia patients.
    Guest PC; Chan MK; Gottschalk MG; Bahn S
    Biomark Med; 2014; 8(1):15-27. PubMed ID: 24325222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of subgroups of schizophrenia patients with changes in either immune or growth factor and hormonal pathways.
    Schwarz E; van Beveren NJ; Ramsey J; Leweke FM; Rothermundt M; Bogerts B; Steiner J; Guest PC; Bahn S
    Schizophr Bull; 2014 Jul; 40(4):787-95. PubMed ID: 23934781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Independent protein-profiling studies show a decrease in apolipoprotein A1 levels in schizophrenia CSF, brain and peripheral tissues.
    Huang JT; Wang L; Prabakaran S; Wengenroth M; Lockstone HE; Koethe D; Gerth CW; Gross S; Schreiber D; Lilley K; Wayland M; Oxley D; Leweke FM; Bahn S
    Mol Psychiatry; 2008 Dec; 13(12):1118-28. PubMed ID: 17938634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coordinated proteomic signature changes in immune response and complement proteins in acute myocardial infarction: the implication of serum amyloid P-component.
    Cubedo J; Padró T; Badimon L
    Int J Cardiol; 2013 Oct; 168(6):5196-204. PubMed ID: 23992930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular validation of the acute phencyclidine rat model for schizophrenia: identification of translational changes in energy metabolism and neurotransmission.
    Ernst A; Ma D; Garcia-Perez I; Tsang TM; Kluge W; Schwarz E; Guest PC; Holmes E; Sarnyai Z; Bahn S
    J Proteome Res; 2012 Jul; 11(7):3704-14. PubMed ID: 22613019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global proteomic profiling reveals altered proteomic signature in schizophrenia serum.
    Levin Y; Wang L; Schwarz E; Koethe D; Leweke FM; Bahn S
    Mol Psychiatry; 2010 Nov; 15(11):1088-100. PubMed ID: 19546861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2-D DIGE analysis of liver and red blood cells provides further evidence for oxidative stress in schizophrenia.
    Prabakaran S; Wengenroth M; Lockstone HE; Lilley K; Leweke FM; Bahn S
    J Proteome Res; 2007 Jan; 6(1):141-9. PubMed ID: 17203958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Schizophrenia, autoimmunity and immune system dysregulation: a comprehensive model updated and revisited.
    Strous RD; Shoenfeld Y
    J Autoimmun; 2006 Sep; 27(2):71-80. PubMed ID: 16997531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.